Karin Eastham, M.B.A.

Karin Eastham has served as a member Veracyte’s board of directors since 2012. Ms. Eastham is a veteran life sciences industry executive and leader. From 2004 to 2008, she served as Executive Vice President and Chief Operating Officer, and as a member of the board of trustees, of the Burnham Institute for Medical Research, a non-profit corporation engaged in biomedical research. From 1999 to 2004, she was Senior Vice President, Chief Financial Officer and Secretary of Diversa Corporation, a biotechnology company. She previously held similar positions with CombiChem, Inc., a computational chemistry company, and Cytel Corporation, a biopharmaceutical company. Ms. Eastham also held several positions, including Vice President, Finance, at Boehringer Mannheim Corporation, a diagnostics company, from 1976 to 1988. Ms. Eastham currently serves on the board of directors of Personalis, Inc. and has previously served on the boards of Nektar Therapeutics, Geron Corporation, MorphoSys AG, Amylin Pharmaceuticals, Inc., Genoptix, Inc., Tercica, Inc., Trius Therapeutics, Inc. and Illumina, Inc. Ms. Eastham received a B.S. in Accounting and an M.B.A. from Indiana University and is a Certified Public Accountant.